Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brice Campo

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2012
ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterizationMikhail Kalinichev, Mélanie Rouillier, Francoise Girard, et al.
Journal of Neurogenetics|November 19, 2011
Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depressionBrice Campo, Mikhail Kalinichev, Nathalie Lambeng, et al.
Communications Biology|February 24, 2023
Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screeningMarie Miglianico, Judith M Bolscher, Martijn W Vos, et al.
Malaria Journal|October 18, 2024
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profileMyriam El Gaaloul, Andre Marie Tchouatieu, Kassoum Kayentao, et al.
Nucleic Acids Research|November 7, 2019
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGYJane F Armstrong, Elena Faccenda, Simon D Harding, et al.
Clinical Microbiology Reviews|April 28, 2017
Susceptibility Testing of Medically Important ParasitesAbebe Genetu Bayih, Anjan Debnath, Edward Mitre, et al.
Microbiology Spectrum|March 10, 2025
Differential <i>ex vivo</i> susceptibility of <i>Plasmodium malariae</i> and <i>Plasmodium falciparum</i> clinical isolates from Ghana and Mali to current and lead discovery candidate antimalarial drugsAlamissa Soulama, Fanta Sogore, Felix Ansah, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
<i>Plasmodium vivax</i> latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquineErika L Flannery, Niwat Kangwanrangsan, Vorada Chuenchob, et al.
The American Journal of Tropical Medicine and Hygiene|February 8, 2021
Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection StudyMohamed Farouk Chughlay, Myriam El Gaaloul, Cristina Donini, et al.
Journal of Medicinal Chemistry|June 22, 2017
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical CandidateYong-Kang Zhang, Jacob J Plattner, Eric E Easom, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2012
ADX71743, a potent and selective negative allosteric modulator of metabotropic glutamate receptor 7: in vitro and in vivo characterizationMikhail Kalinichev, Mélanie Rouillier, Francoise Girard, et al.
Journal of Neurogenetics|November 19, 2011
Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depressionBrice Campo, Mikhail Kalinichev, Nathalie Lambeng, et al.
Communications Biology|February 24, 2023
Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screeningMarie Miglianico, Judith M Bolscher, Martijn W Vos, et al.
Malaria Journal|October 18, 2024
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profileMyriam El Gaaloul, Andre Marie Tchouatieu, Kassoum Kayentao, et al.
Nucleic Acids Research|November 7, 2019
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGYJane F Armstrong, Elena Faccenda, Simon D Harding, et al.
Clinical Microbiology Reviews|April 28, 2017
Susceptibility Testing of Medically Important ParasitesAbebe Genetu Bayih, Anjan Debnath, Edward Mitre, et al.
Microbiology Spectrum|March 10, 2025
Differential <i>ex vivo</i> susceptibility of <i>Plasmodium malariae</i> and <i>Plasmodium falciparum</i> clinical isolates from Ghana and Mali to current and lead discovery candidate antimalarial drugsAlamissa Soulama, Fanta Sogore, Felix Ansah, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
<i>Plasmodium vivax</i> latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquineErika L Flannery, Niwat Kangwanrangsan, Vorada Chuenchob, et al.
The American Journal of Tropical Medicine and Hygiene|February 8, 2021
Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection StudyMohamed Farouk Chughlay, Myriam El Gaaloul, Cristina Donini, et al.
Journal of Medicinal Chemistry|June 22, 2017
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical CandidateYong-Kang Zhang, Jacob J Plattner, Eric E Easom, et al.
Pageof 6